Cargando…

Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients

OBJECTIVE: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated re...

Descripción completa

Detalles Bibliográficos
Autores principales: Okroglic, Sandra, Widmann, Catherine N., Urbach, Horst, Scheltens, Philip, Heneka, Michael T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564848/
https://www.ncbi.nlm.nih.gov/pubmed/23393549
http://dx.doi.org/10.1371/journal.pone.0053455
_version_ 1782258369976860672
author Okroglic, Sandra
Widmann, Catherine N.
Urbach, Horst
Scheltens, Philip
Heneka, Michael T.
author_facet Okroglic, Sandra
Widmann, Catherine N.
Urbach, Horst
Scheltens, Philip
Heneka, Michael T.
author_sort Okroglic, Sandra
collection PubMed
description OBJECTIVE: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated retrospectively in a cohort of CM patients. METHODS: Patients treated at the Department of Neurology, University of Bonn for CM (n = 223; 98m, 125f; aged 77.32±9.09) from 2005 to 2010 were retrospectively enrolled. Clinical symptoms, blood chemistry, potential risk factors, demographic data and ratings of vascular pathology in the brain based on the Wahlund scale were analyzed using Pearson's chi square test and one-way ANOVA. RESULTS: Progressive cognitive decline (38.1%), gait apraxia (27.8%), stroke-related symptoms and seizures (24.2%), TIA-symptoms (22%) and vertigo (17%) were frequent symptoms within the study population. Frontal lobe WMLs/lacunar infarcts led to more frequent presentation of progressive cognitive decline, seizures, gait apraxia, stroke-related symptoms, TIA, vertigo and incontinence. Parietooccipital WMLs/lacunar infarcts were related to higher frequencies of TIA, seizures and incontinence. Basal ganglia WMLs/lacunar infarcts were seen in patients with more complaints of gait apraxia, vertigo and incontinence. Age (p = .012), arterial hypertension (p<.000), obesity (p<.000) and cerebral macroangiopathy (p = .018) were positively related to cerebral lesion load. For increased glucose level, homocysteine, CRP and D-Dimers there was no association. CONCLUSION: This underlines the association of CM with neurological symptoms upon admission in a topographical manner. Seizures and vertigo are symptoms of CM which may have been missed in previous studies. In addition to confirming known risk factors such as aging and arterial hypertension, obesity appears to increase the risk as well. Since the incidence of CM is increasing, future studies should focus on the importance of prevention of vascular risk factors on its pathogenesis.
format Online
Article
Text
id pubmed-3564848
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35648482013-02-07 Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients Okroglic, Sandra Widmann, Catherine N. Urbach, Horst Scheltens, Philip Heneka, Michael T. PLoS One Research Article OBJECTIVE: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated retrospectively in a cohort of CM patients. METHODS: Patients treated at the Department of Neurology, University of Bonn for CM (n = 223; 98m, 125f; aged 77.32±9.09) from 2005 to 2010 were retrospectively enrolled. Clinical symptoms, blood chemistry, potential risk factors, demographic data and ratings of vascular pathology in the brain based on the Wahlund scale were analyzed using Pearson's chi square test and one-way ANOVA. RESULTS: Progressive cognitive decline (38.1%), gait apraxia (27.8%), stroke-related symptoms and seizures (24.2%), TIA-symptoms (22%) and vertigo (17%) were frequent symptoms within the study population. Frontal lobe WMLs/lacunar infarcts led to more frequent presentation of progressive cognitive decline, seizures, gait apraxia, stroke-related symptoms, TIA, vertigo and incontinence. Parietooccipital WMLs/lacunar infarcts were related to higher frequencies of TIA, seizures and incontinence. Basal ganglia WMLs/lacunar infarcts were seen in patients with more complaints of gait apraxia, vertigo and incontinence. Age (p = .012), arterial hypertension (p<.000), obesity (p<.000) and cerebral macroangiopathy (p = .018) were positively related to cerebral lesion load. For increased glucose level, homocysteine, CRP and D-Dimers there was no association. CONCLUSION: This underlines the association of CM with neurological symptoms upon admission in a topographical manner. Seizures and vertigo are symptoms of CM which may have been missed in previous studies. In addition to confirming known risk factors such as aging and arterial hypertension, obesity appears to increase the risk as well. Since the incidence of CM is increasing, future studies should focus on the importance of prevention of vascular risk factors on its pathogenesis. Public Library of Science 2013-02-05 /pmc/articles/PMC3564848/ /pubmed/23393549 http://dx.doi.org/10.1371/journal.pone.0053455 Text en © 2013 Okroglic et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Okroglic, Sandra
Widmann, Catherine N.
Urbach, Horst
Scheltens, Philip
Heneka, Michael T.
Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients
title Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients
title_full Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients
title_fullStr Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients
title_full_unstemmed Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients
title_short Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients
title_sort clinical symptoms and risk factors in cerebral microangiopathy patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564848/
https://www.ncbi.nlm.nih.gov/pubmed/23393549
http://dx.doi.org/10.1371/journal.pone.0053455
work_keys_str_mv AT okroglicsandra clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients
AT widmanncatherinen clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients
AT urbachhorst clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients
AT scheltensphilip clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients
AT henekamichaelt clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients